Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,029 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Failure patterns after intravascular brachytherapy for in-stent coronary restenosis.
Wallner K, Kearney KE, Kim M, Tiwana J, Elison D, Kim EY, Parvathaneni U, Lombardi WL, Phillips ML, Don C. Wallner K, et al. Among authors: kim ey, kim m. Catheter Cardiovasc Interv. 2022 Nov;100(5):759-762. doi: 10.1002/ccd.30399. Epub 2022 Sep 13. Catheter Cardiovasc Interv. 2022. PMID: 36098336 Review.
Intravascular coronary brachytherapy combined with a drug-coated balloon.
Kearney KE, Wallner K, Kim M, Hira RS, Kim EY, Nakamura K, Parvathaneni U, Steinberg ZL, McCabe JM, Lombardi WL, Phillips ML, Don C. Kearney KE, et al. Among authors: kim ey, kim m. Brachytherapy. 2021 Nov-Dec;20(6):1276-1281. doi: 10.1016/j.brachy.2021.04.002. Epub 2021 Jul 2. Brachytherapy. 2021. PMID: 34226148
Brachytherapy: update and results.
Ellis RJ, Kim E. Ellis RJ, et al. Curr Urol Rep. 2003 Jun;4(3):233-9. doi: 10.1007/s11934-003-0075-2. Curr Urol Rep. 2003. PMID: 12756088 Review.
Long-term Outcomes for Extraskeletal Myxoid Chondrosarcoma: A SEER Database Analysis.
Wagner MJ, Chau B, Loggers ET, Pollack SM, Kim TS, Kim EY, Thompson MJ, Harwood JL, Cranmer LD. Wagner MJ, et al. Among authors: kim ts, kim ey. Cancer Epidemiol Biomarkers Prev. 2020 Nov;29(11):2351-2357. doi: 10.1158/1055-9965.EPI-20-0447. Epub 2020 Aug 20. Cancer Epidemiol Biomarkers Prev. 2020. PMID: 32856598
Recurrence Risk Related Rationale.
Kim E, Roberts J. Kim E, et al. Int J Radiat Oncol Biol Phys. 2022 Jan 1;112(1):38. doi: 10.1016/j.ijrobp.2021.07.1705. Int J Radiat Oncol Biol Phys. 2022. PMID: 34919880 No abstract available.
Neoadjuvant Therapy Induces a Potent Immune Response to Sarcoma, Dominated by Myeloid and B Cells.
Goff PH, Riolobos L, LaFleur BJ, Spraker MB, Seo YD, Smythe KS, Campbell JS, Pierce RH, Zhang Y, He Q, Kim EY, Schaub SK, Kane GM, Mantilla JG, Chen EY, Ricciotti R, Thompson MJ, Cranmer LD, Wagner MJ, Loggers ET, Jones RL, Murphy E, Blumenschein WM, McClanahan TK, Earls J, Flanagan KC, LaFranzo NA, Kim TS, Pollack SM. Goff PH, et al. Among authors: kim ts, kim ey. Clin Cancer Res. 2022 Apr 14;28(8):1701-1711. doi: 10.1158/1078-0432.CCR-21-4239. Clin Cancer Res. 2022. PMID: 35115306 Free PMC article.
2,029 results